Literature DB >> 15812508

Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.

Massimiliano Gnecchi, Huamei He, Olin D Liang, Luis G Melo, Fulvio Morello, Hui Mu, Nicolas Noiseux, Lunan Zhang, Richard E Pratt, Joanne S Ingwall, Victor J Dzau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15812508     DOI： 10.1038/nm0405-367

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  578 in total

Review 1.  Therapeutic applications of adipose-derived stem cells in cardiovascular disease.

Authors:  Kyle Bruun; Erika Schermer; Anjali Sivendra; Emily Valaik; Reed B Wise; Rana Said; John R Bracht
Journal:  Am J Stem Cells       Date:  2018-10-01

Review 2.  Revisiting cardiovascular regeneration with bone marrow-derived angiogenic and vasculogenic cells.

Authors:  Sangho Lee; Young-Sup Yoon
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

Review 3.  Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step.

Authors:  James D Richardson; Adam J Nelson; Andrew C W Zannettino; Stan Gronthos; Stephen G Worthley; Peter J Psaltis
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 4.  Mesenchymal stromal cells (MSCs): science and f(r)iction.

Authors:  Karen Bieback; Patrick Wuchter; Daniel Besser; Werner Franke; Matthias Becker; Michael Ott; Martin Pacher; Nan Ma; Christof Stamm; Harald Klüter; Albrecht Müller; Anthony D Ho
Journal:  J Mol Med (Berl)       Date:  2012-05-31       Impact factor: 4.599

Review 5.  Genetic engineering of mesenchymal stem cells and its application in human disease therapy.

Authors:  Conrad P Hodgkinson; José A Gomez; Maria Mirotsou; Victor J Dzau
Journal:  Hum Gene Ther       Date:  2010-10-22       Impact factor: 5.695

6.  Effect of disruption of Akt-1 of lin(-)c-kit(+) stem cells on myocardial performance in infarcted heart.

Authors:  Andy Tseng; Joan Stabila; Beth McGonnigal; Naohiro Yano; Mao-Jing Yang; Yi-Tang Tseng; Pamela A Davol; Lawrence G Lum; James F Padbury; Ting C Zhao
Journal:  Cardiovasc Res       Date:  2010-04-21       Impact factor: 10.787

7.  Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.

Authors:  Jing Huang; Zhiping Zhang; Jian Guo; Aiguo Ni; Arjun Deb; Lunan Zhang; Maria Mirotsou; Richard E Pratt; Victor J Dzau
Journal:  Circ Res       Date:  2010-04-08       Impact factor: 17.367

Review 8.  Stem cells and cardiac repair: a critical analysis.

Authors:  Jonathan H Dinsmore; Nabil Dib
Journal:  J Cardiovasc Transl Res       Date:  2008-01-31       Impact factor: 4.132

Review 9.  Bone marrow-derived cell therapy in chagasic cardiac disease: a review of pre-clinical and clinical results.

Authors:  Antonio Carlos Campos de Carvalho; Adriana Bastos Carvalho; Debora Bastos Mello; Regina Coeli Dos Santos Goldenberg
Journal:  Cardiovasc Diagn Ther       Date:  2012-09

10.  IL-15: a novel prosurvival signaling pathway in cardiomyocytes.

Authors:  Yerem Yeghiazarians; Norman Honbo; Isabella Imhof; Brandon Woods; Vanessa Aguilera; Jianqin Ye; Andrew J Boyle; Joel S Karliner
Journal:  J Cardiovasc Pharmacol       Date:  2014-05       Impact factor: 3.105
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.